- Home
- APLS vs ASB Comparison
APLS vs ASB Comparison
Compare APLS & ASB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLS
- ASB
- Stock Information
- Founded
- APLS 2009
- ASB 1861
- Country
- APLS United States
- ASB United States
- Employees
- APLS N/A
- ASB N/A
- Industry
- APLS Biotechnology: Pharmaceutical Preparations
- ASB Major Banks
- Sector
- APLS Health Care
- ASB Finance
- Exchange
- APLS Nasdaq
- ASB Nasdaq
- Market Cap
- APLS 3.5B
- ASB 4.0B
- IPO Year
- APLS 2017
- ASB N/A
- Fundamental
- Price
- APLS $27.97
- ASB $26.51
- Analyst Decision
- APLS Buy
- ASB Hold
- Analyst Count
- APLS 20
- ASB 11
- Target Price
- APLS $34.11
- ASB $27.64
- AVG Volume (30 Days)
- APLS 3.0M
- ASB 1.4M
- Earning Date
- APLS 07-31-2025
- ASB 07-24-2025
- Dividend Yield
- APLS N/A
- ASB 3.47%
- EPS Growth
- APLS N/A
- ASB N/A
- EPS
- APLS N/A
- ASB 0.78
- Revenue
- APLS $754,649,000.00
- ASB $1,035,964,000.00
- Revenue This Year
- APLS $10.84
- ASB $56.79
- Revenue Next Year
- APLS $10.51
- ASB $5.69
- P/E Ratio
- APLS N/A
- ASB $33.77
- Revenue Growth
- APLS 20.02
- ASB 3.82
- 52 Week Low
- APLS $16.10
- ASB $18.32
- 52 Week High
- APLS $41.94
- ASB $28.18
- Technical
- Relative Strength Index (RSI)
- APLS 74.59
- ASB 65.38
- Support Level
- APLS $26.23
- ASB $25.01
- Resistance Level
- APLS $28.87
- ASB $25.49
- Average True Range (ATR)
- APLS 1.07
- ASB 0.57
- MACD
- APLS 0.18
- ASB 0.15
- Stochastic Oscillator
- APLS 84.04
- ASB 96.28
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.
About ASB Associated Banc-Corp
Associated Banc-Corp is a bank holding company. The company through its subsidiaries provides a broad array of banking and nonbanking products and services to individuals and businesses. The company operates in three reportable segments; Corporate and Commercial Specialty; Community, Consumer, and Business; and Risk Management and Shared Services. The majority of its revenue is derived from the Corporate and Commercial Specialty and Community, Consumer, and Business segments.